SD, K., G, L., FGA, J., IME, D., NAG, L., DM, B., . . . NP, v. E. (2019). Use of the Child-Pugh score in anticancer drug dosing decision making: Proceed with caution - Authors' reply. The Lancet. Oncology, 20(6), e290. https://doi.org/10.1016/S1470-2045(19)30349-3
Chicago Style (17th ed.) CitationSD, Krens, Lassche G, Jansman FGA, Desar IME, Lankheet NAG, Burger DM, van Herpen CML, and van Erp NP. "Use of the Child-Pugh Score in Anticancer Drug Dosing Decision Making: Proceed with Caution - Authors' Reply." The Lancet. Oncology 20, no. 6 (2019): e290. https://doi.org/10.1016/S1470-2045(19)30349-3.
MLA (9th ed.) CitationSD, Krens, et al. "Use of the Child-Pugh Score in Anticancer Drug Dosing Decision Making: Proceed with Caution - Authors' Reply." The Lancet. Oncology, vol. 20, no. 6, 2019, p. e290, https://doi.org/10.1016/S1470-2045(19)30349-3.